Pure Global
NCT06148870

Comparison of Efficacy Between Two Myopia Control Lenses

Essilor International·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Myopia
Drug/Device/Intervention
Myopia Control Lens-1 (MCL1)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Essilor International
Location
Singapore, Singapore
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Apr 01, 2025
Enrollment
50 participants
Primary outcome

Change in Axial Length

Summary

This is a one-year, mono-centre, randomize, double-masked, monocular cross-over clinical
 trial designed to test and compare the efficacy of the new lens design in slowing down the
 increase of axial length and controlling myopia progression.

ICD-10 classifications
MyopiaDegenerative myopiaAmblyopia ex anopsiaOcular myiasisMyiasis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06148870
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06148870 through Pure Global AI's free database. This phase not specified trial is sponsored by Essilor International and is currently Not yet recruiting. The study focuses on Myopia. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.